Agios Pharmaceuticals (AGIO) Leases (2019 - 2025)
Historic Leases for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q3 2025 value amounting to $33.6 million.
- Agios Pharmaceuticals' Leases fell 2659.41% to $33.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.6 million, marking a year-over-year decrease of 2659.41%. This contributed to the annual value of $42.9 million for FY2024, which is 2119.13% down from last year.
- Per Agios Pharmaceuticals' latest filing, its Leases stood at $33.6 million for Q3 2025, which was down 2659.41% from $36.8 million recorded in Q2 2025.
- Agios Pharmaceuticals' Leases' 5-year high stood at $82.2 million during Q1 2021, with a 5-year trough of $33.6 million in Q3 2025.
- In the last 5 years, Agios Pharmaceuticals' Leases had a median value of $59.9 million in 2023 and averaged $59.2 million.
- Its Leases has fluctuated over the past 5 years, first crashed by 1005.69% in 2021, then tumbled by 2659.41% in 2025.
- Quarter analysis of 5 years shows Agios Pharmaceuticals' Leases stood at $75.1 million in 2021, then fell by 13.3% to $65.1 million in 2022, then dropped by 16.46% to $54.4 million in 2023, then decreased by 21.19% to $42.9 million in 2024, then fell by 21.52% to $33.6 million in 2025.
- Its Leases stands at $33.6 million for Q3 2025, versus $36.8 million for Q2 2025 and $39.9 million for Q1 2025.